By: WHO Board Considers Reform, Director Re-Election, Key IP-Related Issues | Intellectual Property Watch

Mon, 16 Jan 2012 18:06:59 +0000

[...] Chan did not directly mention the issue of counterfeit and substandard medical products by name, perhaps because of the difficulty in finding acceptable words by which to refer to it. The issue of “substandard/spurious/falsely-labelled/falsified/counterfeit medical products” – as it has been dubbed by member states in an effort to appease all sides – has been controversial at WHO in recent years. But members managed to agree in October on a new mechanism for addressing the issue (IPW, WHO, 1 November 2011). [...]

Comments on: WHO Group Agrees On New Mechanism To Fight Poor-Quality Medicines

By: WHO Board Considers Reform, Director Re-Election, Key IP-Related Issues | Intellectual Property Watch